How many insider declarations does Clover Biopharmaceuticals, Ltd. - B have?

Clover Biopharmaceuticals, Ltd. - B has filed 26 insider declarations with HKEX.

Who is the top reporting insider at Clover Biopharmaceuticals, Ltd. - B?

The top reporting insider at Clover Biopharmaceuticals, Ltd. - B is Liang Peng, based on the count of public filings.

What is the net insider buy vs sell volume on Clover Biopharmaceuticals, Ltd. - B?

Across the available history, declared buys total 0 and disposals 429k€.

InsidersTradesSigma

← Companies ★ Sign in to follow

Clover Biopharmaceuticals, Ltd. - B: insider trades · Hong Kong · HKEX

HKEX:clover-biopharmaceuticals-ltd-bHK·HKEXMcap 312M€Healthcare

AMF ↗

Discover the full insider trade history of Clover Biopharmaceuticals, Ltd. - B, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Clover Biopharmaceuticals, Ltd. - B has recorded 26 insider filings. Market capitalisation: €312.4m. The latest transaction was reported on 24 April 2026 — Sale. Among the most active insiders: Liang Peng. Every trade is accessible without an account.

26

Insider Decl.

0

Thresholds

·

11 ops.

Buy Volume

€429,331

6 ops.

Sell Volume

Financial data

FY ended December 2024 · cache

2.46 €

Income statement

Revenue38.4 M€

Gross profit21.6 M€56% margin

Net income−903.4 M€-2351.5% margin

Balance sheet & cash

Market cap312.4 M€

Total debt89.6 M€

Free Cash Flow−290.1 M€

Last declaration on 24 April 2026

All Executives26 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations

About Clover Biopharmaceuticals, Ltd. - B

Clover Biopharmaceuticals, Ltd. is a biopharmaceutical company focused on developing vaccines and therapies for infectious diseases. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.